Join us at the Euro-BioImaging User Forum on Image Data, for an afternoon of presentations from Euro-BioImaging users and image data/image analysis experts at our Nodes that will provide a compelling overview of the state-of-the-art in Image Data. At this event, Katrín Möller of the University of Iceland, and Isabel Kemmer, Euro-BioImaging’s Image Data Steward, explore their experience of submitting large light-sheet microscopy datasets to the BioImage Archive.
What: Euro-BioImaging User Forum “Image Data”
When: March 26, 2024, from 14:00-17:00 CESTWhere: Online
Light-sheet microscopy: what to do with my large imaging data?
Katrín Möller,
University of Iceland
Isabel Kemmer
Euro-BioImaging ERIC
Many of our current biological questions cannot be answered without visualising the object, interaction, or behaviour under investigation. Therefore, microscopy has become an essential tool for many life scientists. While microscopy technologies are rapidly advancing, with increasing speed, resolution, and sensitivity, the amount of data these instruments generate is also steadily growing.
This presents a new challenge for most institutions: how to manage and store their large datasets.
During her doctoral research Katrín Möller used state-of-the-art light-sheet microscopy to investigate, in real-time, the dynamic movements of various intracellular components within microglia, the immune cell of the brain, during their crucial role in clearing apoptotic cells from the developing zebrafish brain.
This research generated several terabytes of data, taking up significant storage space even after careful curation. As publication and a lab transition approached, securing a long-term, open-access repository for this valuable dataset became necessary. Fortunately, the BioImage Archive came to the rescue.
More news from Euro-BioImaging
September 2, 2026
Collaborate on the Development of PRISM: Standardized Metadata for Preclinical Imaging Datasets
The FoundingGIDE Preclinical Stream, in collaboration with Euro-BioImaging and international partners, has launched a new survey to support the development of PRISM (PReclinical…
Understanding therapy resistance in the tumour microenvironment
Therapies that target rapidly dividing cells have transformed the treatment of many cancers. Yet some promising therapies lose their effectiveness over time, allowing…